Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03095248
Title Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601)
Acronym SEL-TH-1601
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.